Lev Pharmaceuticals, Inc. to Present at the Collins Stewart 4th Annual Growth Conference

NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Collins Stewart 4th Annual Growth Conference, being held July 8-10 at the Mandarin Oriental Hotel in New York City, NY. Dr. Schein will present a corporate progress report, including an update on the Company's lead product candidate, Cinryze™ [C1 inhibitor (human)]. The Lev presentation is scheduled to begin at 10:00 a.m. Eastern Standard Time on Thursday, July 10th.